PyInvesting

Market research

4577.TSE Daito Pharmaceutical Co.,Ltd

TSE JPY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
37B
P/E ratio
12.49
Analyst target
1400
Dividend yield
3.1%
Beta
0.18

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Daito Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 7.1% below its 200 day moving average.

From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.

Daito Pharmaceutical Co.,Ltd's total revenue rose by 6.4% to $12B since the same quarter in the previous year.

Its net income has increased by 1.8% to $1B since the same quarter in the previous year.

Based on the above factors, Daito Pharmaceutical Co.,Ltd gets an overall score of 3/5.